Mark Charbonneau

Title: Mark Charbonneau: Innovator in Immunomodulatory Compositions

Introduction

Mark Charbonneau is a notable inventor based in Medford, MA (US). He has made significant contributions to the field of immunology through his innovative work on microbial entities. With a total of 2 patents, Charbonneau is recognized for his advancements in compositions aimed at treating immune system disorders.

Latest Patents

Charbonneau's latest patents focus on immunomodulatory compositions comprising microbial entities. These disclosures provide for compositions, including pharmaceutical compositions, dietary supplements, medical foods, and food products. The compositions consist of combinations of live microbe populations designed for the treatment and prevention of immune system disorders and conditions related to inflammation. This includes both pathogen-assisted conditions and those independent of pathogens. The patents also detail methods for using these compositions and selecting microbial entities for formulation.

Career Highlights

Mark Charbonneau is currently associated with Solarea Bio, Inc., where he continues to develop innovative solutions in the field of immunology. His work is pivotal in advancing the understanding and treatment of immune-related conditions.

Collaborations

Charbonneau collaborates with notable colleagues, including Eric Michael Schott and Gerardo V Toledo. Their combined expertise contributes to the innovative research and development at Solarea Bio, Inc.

Conclusion

Mark Charbonneau's contributions to immunomodulatory compositions highlight his role as a leading inventor in the field. His work not only advances scientific knowledge but also has the potential to improve health outcomes for individuals with immune system disorders.